Albumin in Chronic Liver Disease: Structure, Functions and Therapeutic Implications

Overview

Journal Hepatol Int

Publisher Springer

Specialty Gastroenterology

Date 2015 Oct 1

PMID 26420218

Citations 90

Authors

Rosaria Spinella

Rohit Sawhney

Rajiv Jalan

Affiliations

Soon will be listed here.

Abstract

Human serum albumin is a critical plasma protein produced by the liver with a number of accepted clinical indications in chronic liver disease including management of circulatory and renal dysfunction in patients with ascites. Advanced cirrhosis is characterised by reduced albumin concentration as well as impaired albumin function as a result of specific structural changes and oxidative damage. Traditionally, the biologic and therapeutic role of albumin in liver disease was attributed to its oncotic effects but it is now understood that albumin has a wide range of other important physiologic functions such as immunomodulation, endothelial stabilisation, antioxidant effects and binding multiple drugs, toxins and other molecules. This review discusses the multifunctional properties of albumin and, in particular, the biologic and clinical implications of structural and functional changes of albumin that are associated with cirrhosis. Based on these insights, we explore the current and potential future therapeutic uses of albumin in liver disease.

Citing Articles

Amelioration of Alcoholic Hepatic Steatosis in a Rat Model via Consumption of Poly-γ-Glutamic Acid-Enriched Fermented Larvae Using .

Sim S, Cho H, Lee S Foods. 2025; 14(5).

PMID: 40077563 PMC: 11899319. DOI: 10.3390/foods14050861.

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy.

Luo M, Wei H, Qiu M, Su C, Ning R, Zhou S Front Immunol. 2025; 16:1473962.

PMID: 40013138 PMC: 11861202. DOI: 10.3389/fimmu.2025.1473962.

Nomogram model based on γ-glutamyl transferase to albumin ratio predicts survival in hepatocellular carcinoma patients with transarterial chemoembolization treatment.

Wu Z, Li H, Chen J, Su K, Weng M, Han Y World J Gastrointest Oncol. 2024; 16(12):4650-4662.

PMID: 39678787 PMC: 11577374. DOI: 10.4251/wjgo.v16.i12.4650.

Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD.

Dong K, Zheng Y, Wang Y, Guo Q Sci Rep. 2024; 14(1):30403.

PMID: 39638820 PMC: 11621551. DOI: 10.1038/s41598-024-80801-8.

A review of enhanced recovery after surgery concept in perioperative radical prostatectomy for prostate cancer.

Wu C, Jiang X, Shi Y, Lv Z J Robot Surg. 2024; 19(1):9.

PMID: 39585492 DOI: 10.1007/s11701-024-02170-8.

References

Tarao K, Iwamura K . Influence of long-term administration of serum albumin on the prognosis of liver cirrhosis in man. Tokai J Exp Clin Med. 1983; 8(1):71-8. View

Banares R, Nevens F, Larsen F, Jalan R, Albillos A, Dollinger M . Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2012; 57(3):1153-62. DOI: 10.1002/hep.26185. View

. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010; 53(3):397-417. DOI: 10.1016/j.jhep.2010.05.004. View

Cantin A, Paquette B, Richter M, Larivee P . Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation. Am J Respir Crit Care Med. 2000; 162(4 Pt 1):1539-46. DOI: 10.1164/ajrccm.162.4.9910106. View

Arvaniti V, DAmico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M . Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010; 139(4):1246-56, 1256.e1-5. DOI: 10.1053/j.gastro.2010.06.019. View

Jalan R, Schnurr K, Mookerjee R, Sen S, Cheshire L, Hodges S . Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality. Hepatology. 2009; 50(2):555-64. DOI: 10.1002/hep.22913. View

Garcia-Martinez R, Andreola F, Mehta G, Poulton K, Oria M, Jover M . Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure. J Hepatol. 2014; 62(4):799-806. DOI: 10.1016/j.jhep.2014.10.031. View

Bernardi M, Caraceni P, Navickis R, Wilkes M . Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2011; 55(4):1172-81. DOI: 10.1002/hep.24786. View

Simon-Talero M, Garcia-Martinez R, Torrens M, Augustin S, Gomez S, Pereira G . Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol. 2013; 59(6):1184-92. DOI: 10.1016/j.jhep.2013.07.020. View

10.

Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P . Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int. 2010; 30(7):937-47. DOI: 10.1111/j.1478-3231.2010.02272.x. View

11.

Oettl K, Birner-Gruenberger R, Spindelboeck W, Stueger H, Dorn L, Stadlbauer V . Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J Hepatol. 2013; 59(5):978-83. DOI: 10.1016/j.jhep.2013.06.013. View

12.

Klammt S, Brinkmann B, Mitzner S, Munzert E, Loock J, Stange J . Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers. Z Gastroenterol. 2005; 39 Suppl 2:24-7. DOI: 10.1055/s-2001-919056. View

13.

Kragh-Hansen U, Chuang V, Otagiri M . Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull. 2002; 25(6):695-704. DOI: 10.1248/bpb.25.695. View

14.

Jaeschke H, Hasegawa T . Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006; 26(8):912-9. DOI: 10.1111/j.1478-3231.2006.01327.x. View

15.

Moller S, Henriksen J . Cirrhotic cardiomyopathy. J Hepatol. 2010; 53(1):179-90. DOI: 10.1016/j.jhep.2010.02.023. View

16.

Oettl K, Stauber R . Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol. 2007; 151(5):580-90. PMC: 2013999. DOI: 10.1038/sj.bjp.0707251. View

17.

Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K . Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 1999; 12(6):439-46. DOI: 10.1093/protein/12.6.439. View

18.

Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C . Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology. 2012; 142(4):782-789.e3. DOI: 10.1053/j.gastro.2011.12.056. View

19.

Qiao R, Lum H, Tiruppathi C, Malik A . Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. Am J Physiol. 1993; 265(2 Pt 1):C439-46. DOI: 10.1152/ajpcell.1993.265.2.C439. View

20.

Quinlan G, Margarson M, Mumby S, Evans T, Gutteridge J . Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond). 1998; 95(4):459-65. View